Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Annales D'Endocrinologie|January 17, 2015
Prostate cancer: The main risk and protective factors-Epigenetic modificationsMawussi Adjakly, Marjolaine Ngollo, Aslihan Dagdemir, et al.
Omics : a Journal of Integrative Biology|April 2, 2015
Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?Seher Karsli-Ceppioglu, Marjolaine Ngollo, Mawussi Adjakly, et al.
Biomed Research International|September 23, 2016
Improved Efficiency and Reliability of NGS Amplicon Sequencing Data Analysis for Genetic Diagnostic Procedures Using AGSA SoftwareAxel Poulet, Maud Privat, Flora Ponelle, et al.
Plos One|June 18, 2015
Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer TherapyInés Omrane, Imen Medimegh, Olfa Baroudi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates AtherosclerosisPierre-Yves Jean-Charles, Jiao-Hui Wu, Lisheng Zhang, et al.
British Journal of Cancer|April 21, 2017
Long-term improvement of breast cancer survivors' quality of life by a 2-week group physical and educational intervention: 5-year update of the 'PACThe' trialFabrice Kwiatkowski, Marie-Ange Mouret-Reynier, Martine Duclos, et al.
Immunology Letters|January 21, 2014
Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancerInés Omrane, Olfa Baroudi, Karim Bougatef, et al.
Anticancer Research|July 18, 2008
DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohortLuc Fontana, Rémy Bosviel, Laetitia Delort, et al.
Cancer Genomics & Proteomics|July 2, 2016
Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype CellsAslihan Dagdemir, Gaëlle Judes, André Lebert, et al.
Molecular Biology Reports|May 24, 2011
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian populationWijden Mahfoudh, Noureddine Bouaouina, Slim Ben Ahmed, et al.
Pageof 24